Scopus BioPharma Inc.

Exited
CIK: 1772028•Delaware•Tier2

Equity (common or preferred stock) · Audited · Healthcare · SIC 2834

$13.8M
Qualified
maximum offering price, as qualified
$0
Reported Sold
1-K 2020-05-15
15
Filings
across 3 offerings

Equity Classes

TypeClassOutstandingCUSIP
commoncommon stock14,577,597809171101
commonoptions and warrants1,707,500—
commonw warrants8,434,438—
debtconvertible promissory notes2,889,835—

Service Providers

RoleProviderCRDFees
auditorCitrin Cooperman & Company, LLP—$30K
legalGreenberg Traurig, LLP—$200K
underwriterThe Benchmark Company, LLC/Joseph Gunnar & Co., LLC22982$950K

Offerings

File NumberFilingsFirst FiledLast FiledQualifiedCommencedPrice/SecuritySecurities OfferedSecurities SoldQualified SoldOutstandingAggregate OfferingProceeds ReportedIssuer PortionSelling HoldersPrior 12mo QualifiedConcurrent OfferingEstimated NetSupplementsLast SupplementCRD
024-1122882020-05-292021-01-262021-01-26—$9.501——14,577,597$12.8M—$9.5M$0$3.3M$0$8.2M42021-01-2822982
024-1113732020-01-072020-05-152020-02-042020-02-10$5.00200,0000200,00012,509,024$1M$0—————42020-09-29—

Current Reports

Filing DateFormEventItems
2020-06-111-UDeparture of Officers7,8,9.1
Embarc dashboard

Operations, the balance sheet and cash flows as filed, year by year — the filer's own captions, not a mapped chart of accounts — plus the tagged figures from every Form 1-A family filing, plotted on the dates they were actually reported. EDGAR still has each 1-K; the dashboard lays every year they filed next to it.

  • Every caption as the filer wrote it, across every annual report — not just the latest 1-K
  • Tagged reported figures across every filing — revenue, assets, cash — with a sparkline on the actual filing dates
  • A sparkline on each annual-statement line, so the shape is visible before the figures
  • A revenue series dated to the filings that reported it
  • A filing history that says what each document contributed, not only that it exists
  • Follow it, and see it change on your watchlist

Part of the Alts plan — $40/mo at launch pricing ($100 list)

External link: SEC Filings